Topics

Single Technologies AB raises SEK 15m to accelerate development of Theta high throughput DNA sequencing platform.

03:35 EST 15 Jan 2020 | BioPortfolio

Stockholm Sweden, January 15, 2020:  Life science instrumentation and genomics company Single Technologies today announced the completion of a heavily oversubscribed SEK 15 m convertible bond issue. JOVB Holding acted as lead investor and the funds will be used to accelerate development of the company’s high throughput DNA sequencing platform Theta.

Single Technologies aims to deliver a paradigm shift in biomolecular analysis with Theta by removing the current limitations of imaging and microfluidics and ensuring true economy of scale in the generation of DNA sequencing data. This would enable the healthcare industry to achieve predictive and prescriptive solutions within DNA data generation and realise the true potential of precision medicine.

The company was founded in 2014 following several years of research into single molecule imaging and biotechnology applications at the Royal Institute of Technology (KTH) in Stockholm, combined with R&D in the fiber optical grating industry by the founders of the fiber optical company, Proximion.

“We are very pleased about the strong interest in the convertible bond issue and it’s a major vote of confidence to have someone like Jens Von Bahr of JOVB Holding, with his strong track record in building companies, investing in our company. Single Technologies’ solution will enable faster and more cost-efficient sequencing of DNA in various types of samples. With the new capital we can further develop our Theta technology and with the next capital raise, which is planned before the summer, we believe we are capitalised to launch a solution that will revolutionise Next Generation Sequencing.” Commented Johan Strömqvist, CEO Single Technologies.

For more information:

Johan Strömqvist, CEO, johan@singletechnologies.com +46735280550

www.singletechnologies.com

Richard Hayhurst

Richard Hayhurst Associates Ltd
Moreton House
High Street
Chipping Campden
Gloucestershire GL55 6AG
UK

T: +44 (0) 7711821527
E:Richard@richardhayhurstassociates.com
W:www.richardhayhurstassociates.com
Skype: richard.hayhurst56

NEXT ARTICLE

More From BioPortfolio on "Single Technologies AB raises SEK 15m to accelerate development of Theta high throughput DNA sequencing platform."

Quick Search

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

DNA sequencing
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...